Project description
Novel peptide vehicles for macromolecule delivery
Gene therapy has great potential for the treatment of many diseases. Non-viral vectors and cell-penetrating materials are gaining ground as safer alternatives to viral vectors for gene delivery. The key objective of the EU-funded TraffikGene project is to develop peptide vehicles for the delivery of customised cargos. Researchers will functionalise peptide/polymer scaffolds with different aldehyde tails and optimise the technology for the delivery of nucleic acids. Moreover, the TraffikGene system can be employed for the transport of antibodies and in cell targeting strategies offering the opportunity for controlled release of macromolecules.
Objective
The delivery of exogenous nucleic acids and related macromolecules is one of the most encouraging tools for the future of human health. However, the delivery of the required genetic cargo still constitutes an important challenge. Although non-viral vectors are still in their preliminary clinical steps they are rising up as a real alternative for gene therapeutics. Oligopeptides and polymer cell penetrating materials constitute one of the most promising alternatives for the protection, transport and controlled release of different macromolecular cargos. Under the framework of the ERC-Stg_DYNAP we have methodology that employs dynamic covalent bonds to connect peptide/polymer scaffolds with different aldehyde tails (cationic, hydrophobic, glycans, PEGs, etc.). This key synthetic advantage allows the quick identification of different peptide vehicles for customized cargos. The recent interest of important industrial partners in our technology confirms the strong interest and potential impact of our platform. TraffikGene will diversify the potential market applications of this technology and will allow us to reach a higher level of control for the market transference. We will optimize peptide libraries for the delivery of new nucleic acids (i.e. mRNA) in in vitro and in vivo. The potential commercial success will be maximized by diversification of the applications in gene therapy, cytosolic delivery, antibody transport, cell targeting, blood brain barrier crossing, etc. A market analysis will identify industrial needs, market niches, financial requirements and stakeholders for commercialization. The best future IPR strategy will be carefully evaluated and decided (i.e. product licensing, product development, spin-off, etc.). TraffikGene will allow us to identify and solve challenges required to improve, diversify and exploit the strong potential market applications of our discoveries in the field of gene and macromolecular controlled delivery.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules nucleic acids
- natural sciences chemical sciences organic chemistry aldehydes
- medical and health sciences medical biotechnology genetic engineering gene therapy
- natural sciences chemical sciences polymer sciences
- natural sciences biological sciences biochemistry biomolecules carbohydrates
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
ERC-POC - Proof of Concept Grant
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) ERC-2018-PoC
See all projects funded under this callHost institution
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
15782 SANTIAGO DE COMPOSTELA
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.